Life in the Time of Coronavirus
/* custom css */
.td_uid_1_5f09488e0b2f9_rand { min-height: 0; }
/* custom css */
.td_uid_2_5f09488e0b531_rand { vertical-align: baseline; }
REGISTER NOW
jQuery(window).load(function () { jQuery('body').find('#td_uid_1_5f09488e0b2f4 .td-element-style').each(function (index, element) { jQuery(element).css('opacity', 1); return; }); }); ...
Bacteriophages Could Be a Potential Game Changer in the Trajectory of COVID-19
The pandemic of the coronavirus disease (COVID-19) has caused the death of at least 270,000 people as of the 8th of May 2020. This work stresses the potential role of bacteriophages to decrease the...
PerkinElmer, Sonora Quest Labs Expand COVID-19 Testing in Arizona
Arizona Gov. Doug Ducey
PerkinElmer is partnering with Sonora Quest Laboratories on an expansion of COVID-19 testing in Arizona, funded in part by the state of Arizona—which has acknowledged spikes in cases of the virus...
Life Sciences Fund Launches with €76M to Invest in Nordic Biotech
Stockholm and Copenhagen-based Eir Ventures has announced the closure of its first fund at €76M, which will be used to invest in biotechs and other life science companies, with a focus on the Nordics.
The...
Commentary in Pediatrics: Children don’t transmit Covid-19, schools should reopen in fall
Rising cases in Texas childcare facilities could be misinterpreted, says commentary author
Credit: www.vperemen.com / CC BY-SA
A commentary published in the journal Pediatrics, the official peer-reviewed journal of the American Academy of Pediatrics, concludes that...
Salmonella biofilm protein can cause autoimmune responses, arthritis in animals
Scientists from the Vaccine and Infectious Disease Organization-International Vaccine Centre (VIDO-InterVac) at the University of Saskatchewan (USask) and Temple University (Philadelphia, U.S.) have demonstrated that a Salmonella biofilm protein can cause autoimmune responses and...
Volunteers can now register for coronavirus disease vaccine trials
As the world grapples with the coronavirus pandemic, many pharmaceutical companies, and research organizations are racing to develop an effective vaccine against the novel coronavirus, called the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Human...
Insilico Medicine, Arctoris announce technology partnership to discover new COVID-19 drugs
Reviewed by Emily Henderson, B.Sc.Jul 9 2020
Insilico Medicine, a biotechnology company developing an end-to-end drug discovery pipeline utilizing next-generation artificial intelligence, today announced a technology partnership with Arctoris, the world's first fully automated drug...
Genexine and NeoImmuneTech (NIT) – GX-I7 [also called NT-17 or Hyleukin-7™ (rhIL-7-hyFc)]
Candidate: GX-I7, also known as NT-17 or Hyleukin-7 (rhIL-7-hyFc)
Type: Homeostatic T cell growth factor composed of a covalently linked homodimer of engineered Interleukin-7 (IL-7) molecule, biologically fused with the proprietary long-acting platform – hyFc....
€18M to Fund First-in-Class Systemic Sclerosis Drug
One of the largest biotech placements in the Nordic countries this year will accelerate the development of a first-in-class drug for chronic inflammation conditions such as systemic sclerosis that lacks the cardiovascular risks of...
